It is more than 20 years since the term ‘Damage control’ was introduced to describe an emerging surgical strategy of abbreviated laparotomy for exsanguinating trauma patients. This strategy of temporisation and prioritisation of physiological recovery over completeness of anatomical repair was associated with improved survival in a subset of patients with combined major vascular and multiple visceral injuries. The ensuing years saw the rapid adoption of these principles as standard of care for massively injured and physiologically exhausted patients. Resuscitation of severely injured patients has changed significantly in the last decade with the emergence of a new resuscitation paradigm termed ‘damage control resuscitation’. Originating in combat support hospitals, damage control resuscitation emphasises the primacy of haemorrhage control while directly targeting the ‘lethal triad’ of coagulopathy, acidosis, and hypothermia. Integral to damage control resuscitation is the appropriate application of damage control surgery and together they constitute the modern damage control paradigm. This review aims to discuss the modern application of damage control resuscitation and damage control surgery and to review the evidence supporting its constituent components, as well as considering deficiencies in current knowledge and areas for future research.
KauvarDSLeferingRWadeCE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma2006; 60(6 Suppl): S3–S11.
2.
TeixeiraPGRInabaKHadjizachariaP. Preventable or potentially preventable mortality at a mature trauma center. J Trauma Acute Care Surg2007; 63: 1338–1347.
3.
SauaiaAMooreFAMooreEE. Epidemiology of trauma deaths: a reassessment. J Trauma Acute Care Surg1995; 38: 185–193.
4.
AcostaJAYangJCWinchellRJ. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg1998; 186: 528–533.
5.
HoytDBBulgerEMKnudsonMM. Death in the operating room: an analysis of a multi-center experience. J Trauma1994; 37: 426–426.
6.
XiaoWMindrinosMNSeokJ. A genomic storm in critically injured humans. J Exp Med2011; 208: 2581–2590.
7.
GruenRLBrohiKSchreiberM. Haemorrhage control in severely injured patients. Lancet2012; 380: 1099–1108.
8.
EastridgeBJMabryRLSeguinP. Death on the battlefield (2001–2011): implications for the future of combat casualty care. J Trauma Acute Care Surg2012; 73(6 Suppl 5): S431–S437.
9.
StoneHHStromPRMullinsRJ. Management of the major coagulopathy with onset during laparotomy. Ann Surg1983; 197: 532–535.
10.
RotondoMFSchwabCWMcGonigalMD. ‘Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma1993; 35: 375–382. discussion: 382–383.
CottonBAGuyJSMorrisJA. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock2006; 26: 115–121.
13.
RheePWangDRuffP. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med2000; 28: 74–78.
14.
SimmonsRLCollinsJAHeisterkampCA. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg1969; 169: 455–482.
BorgmanMASpinellaPCPerkinsJG. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma2007; 63: 805–813.
17.
HolcombJBJenkinsDRheeP. Damage control resuscitation: Directly addressing the early coagulopathy of trauma. J Trauma2007; 62: 307–310.
18.
HodgettsTJMahoneyPFKirkmanE. Damage control resuscitation. J R Army Med Corps2007; 153: 299–300.
19.
CherkasD. Traumatic hemorrhagic shock: advances in fluid management. Emerg Med Pract2011; 13: 1–19. quiz: 19–20.
20.
CottonBAAuBKNunezTC. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma2009; 66: 41–48. discussion: 48–9.
21.
DuchesneJCKimonisKMarrAB. Damage control resuscitation in combination with damage control laparotomy: a survival advantage. J Trauma2010; 69: 46–52.
22.
CottonBAReddyNHatchQM. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg2011; 254: 598–605.
23.
FoxCJGillespieDLCoxED. Damage control resuscitation for vascular surgery in a combat support hospital. J Trauma2008; 65: 1–9.
24.
DuaAPatelBKraghJF. Long-term follow-up and amputation-free survival in 497 casualties with combat-related vascular injuries and damage-control resuscitation. J Trauma Acute Care Surg2012; 73: 1515–1520.
25.
SchreiberMA. The beginning of the end for damage control surgery. Br J Surg2012; 99(Suppl 1): 10–11.
26.
HodgettsTJMahoneyPFRussellMQ. ABC to <C> ABC: redefining the military trauma paradigm. Emerg Med J2006; 23: 745–746.
27.
ChampionHRBellamyRFRobertsCP. A profile of combat injury. J Trauma2003; 54: S13–S19.
28.
LaksteinDBlumenfeldASokolovT. Tourniquets for hemorrhage control on the battlefield: a 4-year accumulated experience. J Trauma2003; 54: S221–S225.
29.
SpahnDRBouillonBCernyV. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care2013; 17: R76–R76.
30.
ScottIPorterKLairdC. The prehospital management of pelvic fractures: initial consensus statement. Emerg Med J2013; 30: 1070–1072.
31.
StewartM. Towards evidence-based emergency medicine: Best bets from the manchester royal infirmary. BET 3: pelvic circumferential compression devices for haemorrhage control: panacea or myth?Emerg Med J2013; 30: 425–456.
32.
JansenJOThomasRLoudonMA. Damage control resuscitation for patients with major trauma. BMJ2009; 338: b1778–b1778.
33.
HahnRG. Fluid therapy in uncontrolled hemorrhage – what experimental models have taught us. Acta Anaesthesiol Scand2013; 57: 16–28.
34.
BickellWHWallMJJrPepePE. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med1994; 331: 1105–1109.
35.
TurnerJNichollJWebberL. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess2000; 4: 1–57.
36.
DuttonRPMackenzieCFScaleaTM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma2002; 52: 1141–1146.
37.
KwanIBunnFRobertsI. Timing and volume of fluid administration for patients with bleeding following trauma. Cochrane Database Syst Rev2001; 1: CD002245–CD002245.
38.
GarnerJWattsSParryC. Prolonged permissive hypotensive resuscitation is associated with poor outcome in primary blast injury with controlled hemorrhage. Ann Surg2010; 251: 1131–1139.
39.
McLaughlinDFNilesSESalinasJ. A predictive model for massive transfusion in combat casualty patients. J Trauma2008; 64(2 Suppl): S57–S63. discussion: S63.
40.
NunezTCVoskresenskyIVDossettLA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)?J Trauma2009; 66: 346–352.
41.
CottonBADossettLAHautER. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma2010; July(69 Suppl 1): S33–S39.
42.
MurdockADBerséusOHervigT. Whole blood: the future of traumatic hemorrhagic shock resuscitation. Shock2014; May(41 Suppl 1): 62–69.
43.
CottonBAPodbielskiJCampE. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg2013; 258: 527–532. discussion: 532–533.
44.
SpinellaPC. Warm fresh whole blood transfusion for severe hemorrhage: US military and potential civilian applications. Crit Care Med2008; 36: S340–S345.
45.
KeneallyRJParsonsAMWillettPB. Warm fresh whole blood and thoracic traumain Iraq and Afghanistan. J Emerg Trauma Shock2015; 8: 21–25.
46.
KashukJLMooreEEJohnsonJL. Postinjury life threatening coagulopathy: is 1: 1 fresh frozen plasma: packed red blood cells the answer?J Trauma2008; 65: 261–271.
47.
SperryJLOchoaJBGunnSR. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma2008; 65: 986–993.
48.
MaegeleMLeferingRPaffrathT. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the trauma registry of the deutsche gesellschaft für unfallchirurgie. Vox Sang2008; 95: 112–119.
49.
HolcombJBWadeCEMichalekJE. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg2008; 248: 447–458.
50.
GonzalezEAMooreFAHolcombJB. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma2007; 62: 112–119.
51.
SpinellaPCPerkinsJGGrathwohlKW. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma2008; 64(2 Suppl): S69–S77. discussion: S77–S78.
52.
SnyderCWWeinbergJAMcGwinGJr. The relationship of blood product ratio to mortality: survival benefit or survival bias?J Trauma2009; 66: 358–364.
53.
HolcombJBdel JuncoDJFoxEE. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg2013; 148: 127–136.
54.
HolcombJBTilleyBCBaraniukS. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA2015; 313: 471–482.
55.
ArmandRHessJR. Treating coagulopathy in trauma patients. Transfus Med Rev2003; 17: 223–231.
56.
PonschabMSchöchlHGabrielC. Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations. Anaesthesia2015; 70: 528–536.
57.
BrinckTHandolinLLeferingR. The effect of evolving fluid resuscitation on the outcome of severely injured patients: an 8-year experience at a tertiary trauma center. Scand J Surg. 19 May 2015. pii: 1457496915586650. [Epub ahead of print.].
58.
SchöchlHNienaberUHoferG. Research goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care2010; 14: R55–R55.
SchöchlHVoelckelWSchlimpCJ. Management of traumatic haemorrhage – the European perspective. Anaesthesia2015; Jan(70 Suppl 1): 102–107. e35–e37.
61.
Da LuzLTNascimentoBShankarakuttyAK. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care2014; 18: 518–518.
62.
ShakurHRobertsIBautistaR. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet2010; 376: 23–32.
63.
RobertsIShakurHAfolabiA. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet2011; 377: 1096–101. 1101.e1–2.
64.
LevyJH. Antifibrinolytic therapy: new data and new concepts. Lancet2010; 376: 3–4.
65.
KenetGWaldenREldadA. Treatment of traumatic bleeding with recombinant factor viia. Lancet1999; 354: 1879–1879.
66.
HortonJDDeZeeKJWagnerM. Use of rfviia in the trauma setting – practice patterns in united states trauma centers. Am Surg2008; 74: 413–417.
67.
WadeCEEastridgeBJJonesJA. Use of recombinant factor viia in US military casualties for a five-year period. J Trauma2010; 69: 353–359.
68.
GhineaNLipworthWKerridgeI. Ethics & evidence in medical debates: the case of recombinant activated factor VII. Hastings Cent Rep2014; 44: 38–45.
69.
BoffardKDRiouBWarrenB. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma2005; 59: 8–15. discussion: 15–18.
70.
HauserCJBoffardKDuttonR. Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma2010; 69: 489–500.
71.
LeviMLevyJHAndersenHF. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med2010; 363: 1791–1800.
72.
SimpsonELinYStanworthS. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev2012; 3: CD005011–CD005011.
73.
KhanSBrohiKChanaM. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma2014; 76: 561–567. discussion: 567–568.
74.
AsensioJADemetriadesDBerneJD. Stapled pulmonary tractotomy: a rapid way to control hemorrhage in penetrating pulmonary injuries. J Am Coll Surg1997; 185: 486–487.
75.
RotondoMFBardMR. Damage control surgery for thoracic injuries. Injury2004; 35: 649–654.
GarciaAMartinezJRodriguezJ. Damage-control techniques in the management of severe lung trauma. J Trauma2015; 78: 45–50. discussion: 50–51.
78.
Rezende-NetoJMarquesACGuedesLJ. Damage control principles applied to penetrating neck and mandibular injury. J Trauma2008; 64: 1142–1143.
79.
LovelandJABoffardKD. Damage control in the abdomen and beyond. Br J Surg2004; 91: 1095–1101.
80.
KhanAHseeLMathurS. Damage-control laparotomy in nontrauma patients: Review of indications and outcomes. J Trauma2013; 75: 365–368.
81.
WeberDGBendinelliCBaloghZJ. Damage control surgery for abdominal emergencies. Br J Surg2014; 101: e109–e118.
82.
PringleJHV. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg1908; 48: 541–549.
83.
HalstedWS. Ligature and suture material: the employment of fine silk in preference to catgut and the advantages of transfixion of tissues and vessels in control of hemorrhage also an account of the introduction of gloves, gutta-percha tissue and silver foil. J Am MedAssoc1913; 60: 1119–1126.
84.
PeitzmanABRichardsonJD. Surgical treatment of injuries to the solid abdominal organs: A 50-year perspective from the journal of trauma. J Trauma2010; 69: 1011–1021.
85.
LeppäniemiA. Who invented damage control surgery?ScandJ Surgery2014; 103: 165–166.
86.
LucasCELedgerwoodAM. Prospective evaluation of hemostatic techniques for liver injuries. J Trauma1976; 16: 442–451.
87.
CalneRYMcMasterPPentlowBD. The treatment of major liver trauma by primary packing with transfer of the patient for definitive treatment. Br J Surg1979; 66: 338–339.
BowleyDMBarkerPBoffardKD. Intraoperative blood salvage in penetrating abdominal trauma: a randomised, controlled trial. World J Surg2006; 30: 1074–1080.
96.
SubramanianAVercruysseGDenteC. A decade's experience with temporary intravascular shunts at a civilian level I trauma center. J Trauma2008; 65: 316–324. discussion: 324–326.
97.
BallCGWyrzykowskiADNicholasJM. A decade's experience with balloon catheter tamponade for the emergency control of hemorrhage. J Trauma2011; 70: 330–333.
98.
ZentaiCBraunschweigTRossaintR. Fibrin patch in a pig model with blunt liver injury under severe hypothermia. J Surg Res2013; 187: 616–624.
99.
MisselbeckTSTeicherEJCipolleMD. Hepatic angioembolization in trauma patients: Indications and complications. J Trauma2009; 67: 769–773.
100.
KushimotoSAraiMAiboshiJ. The role of interventional radiology in patients requiring damage control laparotomy. J Trauma2003; 54: 171–176.
101.
AbramsonDScaleaTMHitchcockR. Lactate clearance and survival following injury. J Trauma1993; 35: 584–589.
102.
ClaridgeJACrabtreeTDPelletierSJ. Persistent occult hypoperfusion is associated with a significant increase in infection rate and mortality in major trauma patients. J Trauma2000; 48: 8–14. discussion: 14–15.
103.
TishermanSABariePBokhariF. Clinical practice guideline: endpoints of resuscitation. J Trauma2004; 57: 898–912.
104.
PommereningMJDuBoseJJZielinskiMD. Time to first take-back operation predicts successful primary fascial closure in patients undergoing damage control laparotomy. Surgery2014; 156: 431–438.
105.
HirshbergAWallMJMattoxKL. Planned reoperation for trauma: a two year experience with 124 consecutive patients. J Trauma1994; 37: 365–369.
106.
MahoneyPFRyanJBrooksAJ. Ballistic trauma: a practical guide, London: Springer Science & Business Media, 2005.
107.
LambCMMacGoeyPNavarroAP. Damage control surgery in the era of damage control resuscitation. Br J Anaesth2014; 113: 242–249.
108.
MillerRSMorrisJADiazJJ. Complications after 344 damage-control open celiotomies. J Trauma2005; 59: 1365–1371. discussion: 1371–1374.
109.
SuttonEBochicchioGVBochicchioK. Long term impact of damage control surgery: a preliminary prospective study. J Trauma2006; 61: 831–834. discussion: 835–836.
110.
NavsariaPThomaMNicolA. Foley catheter balloon tamponade for life-threatening hemorrhage in penetrating neck trauma. World J Surg2006; 30: 1265–1268.
111.
TaiNDicksonEJ. Military junctional trauma. J R Army Med Corps2009; 155: 285–292.
112.
LoperaJE. Embolization in trauma: principles and techniques. Semin Intervent Radiol2010; 27: 14–28.
113.
FuCYWangYCWuSC. Angioembolization provides benefits in patients with concomitant unstable pelvic fracture and unstable hemodynamics. Am J Emerg Med2012; 30: 207–213.
114.
FoxNSchwartzDSalazarJH. Evaluation and management of blunt traumatic aortic injury: a practice management guideline from the eastern association for the surgery of trauma. J Trauma Acute Care Surg2015; 22: 99–110.
115.
UppotRNGarciaMNguyenH. Traumatic common iliac vein disruption treated with an endovascular stent. AJR Am J Roentgenol2001; 177: 606–606.
116.
NoriiTCrandallCTerasakaY. Survival of severe blunt trauma patients treated with resuscitative endovascular balloon occlusion of the aorta compared with propensity score-adjusted untreated patients. J Trauma Acute Care Surg2015; 78: 721–728.
117.
SaitoNMatsumotoHYagiT. Evaluation of the safety and feasibility of resuscitative endovascular balloon occlusion of the aorta. J Trauma Acute Care Surg2015; 78: 897–904.
118.
BifflWLFoxCJMooreEE. The role of REBOA in the control of exsanguinating torso hemorrhage. J Trauma2015; 78: 1054–1058.
